Product
Intrathecal chemotherapy
Aliases
intrathecal chemotherapy
Name
Intrathecal chemotherapy
3 clinical trials
5 indications
Indication
Acute Lymphoblastic LeukemiaIndication
RelapseIndication
Lymphoblastic LymphomaClinical trial
International Proof of Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory HEMatological Malignancies in Children, Subprotocol C Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesStatus: Not yet recruiting, Estimated PCD: 2030-10-01
Clinical trial
International Proof of Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory HEMatological Malignancies in Children, Subprotocol A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesStatus: Not yet recruiting, Estimated PCD: 2029-10-01
Clinical trial
International Proof of Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory HEMatological Malignancies in Children, Subprotocol D: Trametinib + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesStatus: Recruiting, Estimated PCD: 2029-04-01